微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.66% | 138.63% | 95.41% | 38/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.92% | 84.04% | 96% | 50/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2% | 4.17% | 471.43% | 46/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 0.35% | -88.89% | -89.1% | 99/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.21% | -52.58% | 50.7% | 84/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.13% | -56.08% | 10.94% | 80/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.92% | -52.94% | -39.05% | 60/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 3.15% | -88.39% | -53.47% | 98/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 6.77% | -66.57% | 39.59% | 74/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.85% | -61.63% | 18.87% | 70/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 4.08% | -32% | -84.96% | 36/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 27.13% | -7.15% | 33.98% | 22/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 20.25% | -13.24% | 60.21% | 24/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 12.64% | -0.16% | 110.67% | 34/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 6% | 18.81% | -79.47% | 27/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 29.22% | 8.1% | 25.19% | 30/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 23.34% | 4.06% | 84.36% | 20/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 12.66% | -5.66% | 150.69% | 36/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 5.05% | -9.5% | -81.32% | 18/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 27.03% | 10.06% | 20.51% | 21/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 22.43% | 4.13% | 67.14% | 7/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 13.42% | 12.77% | 140.5% | 12/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 5.58% | 2.57% | -77.28% | 7/129 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 24.56% | -26.56% | 14.02% | 23/129 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 21.54% | -29.49% | 81.01% | 3/129 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 11.9% | -41.49% | 118.75% | 4/129 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 5.44% | 2% | -83.73% | 6/129 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 33.44% | -13.03% | 9.46% | 7/129 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 30.55% | 2% | 50.2% | 1/129 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 20.34% | 2% | -47.1% | 2/129 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2016-12-31 | 38.45% | -30.58% | -30.58% | 7/129 | 16.21% | 基蛋生物 | 11.34% | 行业排名> |
| 2015-12-31 | 55.39% | 2% | 2% | 1/129 | 15.95% | 奥泰生物 | 76.87% | 行业排名> |